clinical data

clinical data

EBM
A term defined in the context of a clinical trial for data pertaining to the health status of a patient or subject.
References in periodicals archive ?
To date, only a handful of RHIOs are actually up and running and sharing clinical data, so the horizon is still a bit distant for this concept to apply to nursing homes.
Financial personnel need to see participant data and the services provided but not the clinical data (except for their clinical personnel who may need access to clinical data to make benefits and payment decisions).
Intrasphere Technologies,, a provider of technology consulting and application development to companies in clinical data management has announced the launch of a clinical data management service and two unique technology applications, CRF Maker and Oracle Clinical Progress Monitor, which are designed to increase the efficiency of collecting and managing clinical data.
has announced that its Australian subsidiary, Clinical Data (Australia) Pty.
Forest also today announced that it has agreed with Clinical Data to amend the Merger Agreement, dated as of February 22, 2011, among Forest, Clinical Data, FL Holding C.
Drew Fromkin, previously executive vice president of Clinical Data and president of its PGxHealth division, has been appointed president and chief executive officer of Clinical Data, while Israel M.
There is also increasing need for improved automated clinical data management in documenting treatment, implementing and monitoring best practices protocols, and monitoring quality and risk indicators.
Organized delivery system, capitation payments to providers, practice guidelines, and profiling of physicians' practice habits will all change the power structure in departments of information systems from one that favors financial processing for billing for procedures to clinical processing for clinical data collection, communication, and analysis to make health care services as efficient and effective as possible.
NYSE: FRX) ("Forest") today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the "HSR Act"), has expired in connection with Forest's previously announced acquisition of all outstanding shares of common stock of, and certain outstanding notes and warrants convertible into the common stock of, Clinical Data, Inc.
Acquisition Brings Metabolomics and Biomarker Expertise to Clinical Data
00 per share (the "Contingent Consideration") that may be paid pursuant to the terms of a Contingent Value Agreement to be entered into by Forest, FL Holding CV, an indirect wholly-owned subsidiary of Forest, and Magnolia for the benefit of tendering security holders based upon achievement of certain milestones related to Viibryd[TM], and for certain outstanding notes and warrants issued by Clinical Data that are convertible into or exerciseable for shares of Clinical Data's common stock for the consideration described below.

Full browser ?